Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
This PSD-3, the first pharmaceutical spray dryer built by GEA for OEB-5 products, sets new standards for high-containment pharmaceutical spray drying
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Changhua site meets international regulatory standards for global medical applications
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Subscribe To Our Newsletter & Stay Updated